References
- Jager-Wittenaar H, Dijkstra PU, Dijkstra G, Bijzet J, Langendijk JA, van der Laan BFAM, Roodenburg JLN. High prevalence of cachexia in newly diagnosed head and neck cancer patients: an exploratory study. Nutrition. 2017; 35:114–8. doi:https://doi.org/10.1016/j.nut.2016.11.008
- Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12(5):489–95. doi:https://doi.org/10.1016/S1470-2045(10)70218-7
- Argilés JM, Busquets S, Stemmler B, and López-Soriano FJ, Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014; 14(11):754–62. doi:https://doi.org/10.1038/nrc3829
- Roy A, and, Kumar A. ER stress and unfolded protein response in cancer cachexia. Cancers (Basel). 2019;11(12):1929. doi:https://doi.org/10.3390/cancers11121929
- Almada-Correia I, Neves PM, Mäkitie A, and Ravasco P. Body composition evaluation in head and neck cancer patients: a review. Front Oncol. 2019; 7(9):1112. doi:https://doi.org/10.3389/fonc.2019.01112
- Müller-Richter U, Betz C, Hartmann S, and Brands RC, Nutrition management for head and neck cancer patients improves clinical outcome and survival. Nutr Res. 2017; 48:1–8. doi:https://doi.org/10.1016/j.nutres.2017.08.007
- Blauwhoff-Buskermolen S, Langius JAE, Becker A, Verheul HMW, de van der Schueren MAE, The influence of different muscle mass measurements on the diagnosis of cancer cachexia. J Cachexia Sarcopenia Muscle. 2017; 8(4):615–22.
- Orell-Kotikangas H, Österlund P, Mäkitie O, Saarilahti K, Ravasco P, Schwab U, Mäkitie AA. Cachexia at diagnosis is associated with poor survival in head and neck cancer patients. Acta Otolaryngol. 2017;137(7):778–85. doi:https://doi.org/10.1080/00016489.2016.1277263
- Pérez CDA, Allende PSR, Meneses GA, De Nicola DL, Copca MET, Sánchez LMS, et al. Anorexia-cachexia frequency and its gastrointestinal symptoms association in paliative patients at the Instituto Nacional de Cancerología, México. Nutr. Hosp. 2014; 30(4):891–5. doi:https://doi.org/10.3305/nh.2014.30.4.7674
- Axelsson L, Silander E, Bosaeus I, and, Hammerlid E. Bioelectrical phase angle at diagnosis as a prognostic factor for survival in advanced head and neck cancer. Eur Arch Otorhinolaryngol. 2018;275(9):2379–86. doi:https://doi.org/10.1007/s00405-018-5069-2
- Brown TE, Banks MD, Hughes BGM, Lin CY, Kenny LM, and, Bauer JD, Randomised controlled trial of early prophylactic feeding vs standard care in patients with head and neck cancer. Br J Cancer. 2017; 117(1):15–24. doi:https://doi.org/10.1038/bjc.2017.138
- Jiang W, Ding H, Li W, Ling Y, Hu C, and, Shen C. Benefits of oral nutritional supplements in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy: an exploratory prospective randomized trial. Nutr Cancer. 2018; 70(8):1299–307. doi:https://doi.org/10.1080/01635581.2018.1557222
- Fearon KC, Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer. 2008; 44(8):1124–32. doi:https://doi.org/10.1016/j.ejca.2008.02.033
- Zweers H, Kruizenga H, van den Berg A, Reijven N, Hulshof P. Standard operating procedure SF-BIA. Nutritional Assessment Platform. 2017 [cited 2020 Mar 01]. Available from: www.dieteticpocketguide.com/nap.
- Hernández-Ávila JE, González-Avilés L, Rosales-Mendoza E. Manual de Usuario. SNUT Sistema de Evaluación de Hábitos Nutricionales y Consumo de Nutrimentos. Cuernavaca (Mexico): Instituto Nacional de Salud Pública; 2003.
- Vanhoutte G, van de Wiel M, Wouters K, Sels M, Bartolomeeussen L, De Keersmaecker S, Verschueren C, De Vroey V, De Wilde A, Smits E, et al. Cachexia in cancer: what is in the definition? BMJ Open Gastroenterol. 2016; 3(1):e000097 doi:https://doi.org/10.1136/bmjgast-2016-000097
- Matos L, Teixeira MA, Henriques A, Tavares MM, Alvares L, Antunes A, et al. Nutritional status recording in hospitalized patient notes. Acta Med Port. 2007; 20(6):503–10.
- Kwon M, Kim RB, Roh JL, Lee SW, Kim SB, Choi SH, Nam SY, Kim SY. Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma. Head Neck. 2017;39(4):716–23. doi:https://doi.org/10.1002/hed.24672
- Couch ME, Dittus K, Toth MJ, Willis MS, Guttridge DC, George JR, Barnes CA, Gourin CG, Der-Torossian H. Cancer cachexia update in head and neck cancer: Definitions and diagnostic features. Head Neck. 2015;37(4):594–604. doi:https://doi.org/10.1002/hed.23599
- Nicholson BD, Hamilton W, O'Sullivan J, Aveyard P, Hobbs FR. Weight loss as a predictor of cancer in primary care: a systematic review and meta-analysis. Br J Gen Pract. 2018; 68(670):e311–e322. doi:https://doi.org/10.3399/bjgp18X695801
- Waitzberg DL, Caiaffa WT, Correia MITD. Hospital malnutrition: the Brazilian national survey (IBRANUTRI): a study of 4000 patients. Nutrition. 2001; 17(7–8):573–80. doi:https://doi.org/10.1016/S0899-9007(01)00573-1
- Fuchs V, Barbosa V, Mendoza J, Vargas A, Amancio O, Hernández-Cuéllar A. Effect of an intensive nutritional treatment in nutritional status of head and neck cancer patients in stages III and IV. Nutr Hosp. 2008; 23(2):134.
- Chasen MR, Bhargava R. A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer. Support Care Cancer. 2009; 17(11):1345–51. doi:https://doi.org/10.1007/s00520-009-0684-5
- Hammerlid E, Wirblad B, Sandin C, Mercke C, Edström S, Kaasa S, Sullivan M, Westin T. Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck. 1998; 20(6):540–8. doi:https://doi.org/10.1002/(sici)1097-0347(199809)20:6 < 540::aid-hed9 > 3.0.co;2-j
- Kubrak C, Olson K, Jha N, Jensen L, McCargar L, Seikaly H. Nutrition impact symptoms: key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment. Head Neck. 2010; 32(3):290–300. doi:https://doi.org/10.1002/hed.21174
- Jackson W, Alexander N, Schipper M, Fig L, Feng F, Jolly S. Characterization of changes in total body composition for patients with head and neck cancer undergoing chemoradiotherapy using dual-energy X-ray absorptiometry. Head Neck. 2014; 36(9):1356–62. doi:https://doi.org/10.1002/hed.23461
- Antoun S, Baracos VE, Birdsell L, Escudier B, and Sawyer MB, Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol. 2010; 21(8):1594–8. doi:https://doi.org/10.1093/annonc/mdp605
- Lonkvist CK, Vinther A, Zerahn B, Rosenbom E, Deshmukh AS, Hojman P, Gehl J. Progressive resistance training in head and neck cancer patients undergoing concomitant chemoradiotherapy. Laryngosc Invest Otolaryngol. 2017;2(5):295–306. doi:https://doi.org/10.1002/lio2.88
- Grossberg AJ, Chamchod S, Fuller CD, Mohamed ASR, Heukelom J, Eichelberger H, Kantor ME, Hutcheson KA, Gunn GB, Garden AS, et al. Association of body composition with survival and locoregional control of radiotherapy-treated head and neck squamous cell carcinoma. JAMA Oncol. 2016; 28(6):782–9. doi:https://doi.org/10.1001/jamaoncol.2015.6339
- Riccardi DMDR, das Neves RX, de Matos-Neto EM, Camargo RG, Lima JDCC, Radloff K, Alves MJ, Costa RGF, Tokeshi F, Otoch JP, et al. Plasma lipid profile and systemic inflammation in patients with cancer cachexia. Front Nutr. 2020;7:4. 31;doi:https://doi.org/10.3389/fnut.2020.00004
- Richey LM, George JR, Couch ME, Kanapkey BK, Yin X, Cannon T, Stewart PW, Weissler MC, Shores CG. Defining cancer cachexia in head and neck squamous cell carcinoma. Clin Cancer Res. 2007;13(22 Pt 1):6561–7. doi:https://doi.org/10.1158/1078-0432.CCR-07-0116
- Lai V, George J, Richey L, Kim HJ, Cannon T, Shores C, Couch M. Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract. Head Neck. 2008;30(1):67–74. doi:https://doi.org/10.1002/hed.20662
- Esper DH, Harb WA. The Cancer Cachexia Syndrome: A Review of Metabolic and Clinical Manifestations. Nutr Clin Pract. 2005; 20(4):369–76. doi:https://doi.org/10.1177/0115426505020004369
- Manzato E, Romanato G. Lipid Metabolism in Cachexia. In: Mantovani G, editor Cachexia and Wasting: A Modern Approach. 1st Ed. Milano: Springer Link; 2006. p. 191–4. doi:https://doi.org/10.1007/978-88-470-0552-5_19
- Dessì S, Batetta B, Spano O, Bagby GJ, Tessitore L, Costelli P, Baccino FM, Pani P, Argilès JM. Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130). Br J Cancer. 1995; 72(5):1138–43. doi:https://doi.org/10.1038/bjc.1995.477
- Ding H, Dou S, Ling Y, Zhu G, Wang Q, Wu Y, Qian Y. Longitudinal body composition changes and the importance of fat-free mass index in locally advanced nasopharyngeal carcinoma patients undergoing concurrent chemoradiotherapy. Integr Cancer Ther. 2018;17(4):1125–31. doi:https://doi.org/10.1177/1534735418807969
- Fonseca J, Santos CA, Brito J. Malnutrition and clinical outcome of 234 head and neck cancer patients who underwent percutaneous endoscopic gastrostomy. Nutr Cancer. 2016;68(4):589–97. doi:https://doi.org/10.1080/01635581.2016.1158297